Reverse remodeling during long-term mechanical unloading of the left ventricle (Q36891200)

16 August 2017

1 reference

title

Reverse remodeling during long-term mechanical unloading of the left ventricle (English)

1 reference

16 August 2017

Stavros G Drakos

1

1 reference

16 August 2017

John V Terrovitis

series ordinal

2

1 reference

16 August 2017

Maria I Anastasiou-Nana

series ordinal

3

1 reference

16 August 2017

John N Nanas

series ordinal

4

1 reference

16 August 2017

language of work or name

1 reference

6 June 2007

1 reference

Journal of Molecular and Cellular Cardiology

16 August 2017

published in

1 reference

16 August 2017

volume

43

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

231-242

1 reference

Medical and surgical therapy for cardiac remodeling

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Cellular basis of ventricular remodeling after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Non-invasive assessment of myocardial recovery on chronic left ventricular assist device: results associated with successful device removal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Left ventricular assist system as a bridge to myocardial recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Left ventricular assist device and drug therapy for the reversal of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Improved Left Ventricular Function After Chronic Left Ventricular Unloading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Regression of cellular hypertrophy after left ventricular assist device support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Heterotopic transplantation of the failing rat heart as a model of left ventricular mechanical unloading toward recovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Alterations in Ca2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Cytoskeletal structure and recovery in single human cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Beta-adrenoceptors in cardiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Left ventricular unloading with an assist device results in receptor relocalization as well as increased beta-adrenergic receptor numbers: are these changes indications for outcome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Bridge to recovery with the use of left ventricular assist device and clenbuterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Healing the heart with ventricular assist device therapy: mechanisms of cardiac recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Clenbuterol Induces Hypertrophy of the Latissimus Dorsi Muscle and Heart in the Rat With Molecular and Phenotypic Changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Clenbuterol increases stroke power and contractile speed of skeletal muscle for cardiac assist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Clenbuterol-supported dynamic training of skeletal muscle ventricles against systemic load: a key for powerful circulatory assist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Structure, Regulation, and Function of Mammalian Membrane Guanylyl Cyclase Receptors, With a Focus on Guanylyl Cyclase-A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Recent insights into the role of tumor necrosis factor in the failing heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Differential gene expression and genomic patient stratification following left ventricular assist device support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Mitogen-activated protein kinases in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Decoding calcium signals involved in cardiac growth and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Akt/protein kinase B promotes organ growth in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

"Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

The heme oxygenase system: a regulator of second messenger gases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Reduction of hypoxia-inducible heme oxygenase-1 in the myocardium after left ventricular mechanical support.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Activate NF-kappa B or die?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Differential expression of tissue inhibitors of metalloproteinases in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Enhanced deposition of predominantly type I collagen in myocardial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Immediate effect of aortic valve replacement for aortic stenosis on left ventricular diastolic chamber stiffness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Unloading-induced remodeling in the normal and hypertrophic left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Myocardial histological changes in dilated cardiomyopathy during a long-term left ventricular assist device support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Biventricular assist device-induced right ventricular reverse structural and functional remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Role of mast cells and their mediators in failing myocardium under mechanical ventricular support.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Stretch-induced VEGF expression in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Alterations of gene expression in failing myocardium following left ventricular assist device support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Mixed messages: transcription patterns in failing and recovering human myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Superior Performance of a Paraaortic Counterpulsation Device Compared to the Intraaortic Balloon Pump

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

A valveless high stroke volume counterpulsation device restores hemodynamics in patients with congestive heart failure and intractable cardiogenic shock awaiting heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Preclinical evaluation of the abdominal aortic counterpulsation device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

End-organ function during chronic nonpulsatile circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.05.020

10.1016/J.YJMCC.2007.05.020

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference